Formed by the merger of Gyros AB (founded in 2000) and Protein Technologies, Inc. (founded in 1985), Gyros Protein Technologies AB is a leading provider of solutions for peptide synthesis and bioanalysis. Their focus is on helping scientists in academia and industry to increase biomolecule performance and productivity in research, drug discovery, pre-clinical and clinical development, and bioprocess applications.
Protein Technologies' peptide synthesizers and reagents are used in universities, biotechnology and pharmaceutical companies to deliver uncompromising purity, flexibility, and quality from discovery to pre-clinical studies. With citations in 100’s of publications and use in CMO’s and CRO’s, these peptide synthesis solutions are trusted to generate the highest quality data and synthesize simple to complex multifunctional peptides. Protein Technologies’ PS3™ was launched in 1990, and since then the portfolio has been expanded to include a variety of best-in-class solid phase peptide synthesizers: Tribute®, Prelude® X, Symphony® X, and Sonata®.
Click on logo for further information.